Variant report

Variant	nsv438350
Chromosome Location	chr2:55327091-55333235
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:55327031-55327942	K562	blood:	n/a	chr2:55327796-55327812
2	ATF1	chr2:55327022-55327751	K562	blood:	n/a	n/a
3	ATF3	chr2:55326937-55327390	K562	blood:	n/a	n/a
4	BRCA1	chr2:55326986-55327540	Hela-S3	cervix:	n/a	n/a
5	CEBPB	chr2:55327779-55327912	HepG2	liver:	n/a	n/a
6	CEBPB	chr2:55326958-55327386	A549	lung:	n/a	chr2:55327205-55327216 chr2:55327204-55327215
7	CEBPB	chr2:55327027-55327400	HepG2	liver:	n/a	chr2:55327205-55327216 chr2:55327204-55327215
8	CEBPB	chr2:55327013-55327408	ECC-1	luminal epithelium:	n/a	chr2:55327205-55327216 chr2:55327204-55327215
9	CEBPB	chr2:55329109-55329508	IMR90	lung:	n/a	n/a
10	CEBPB	chr2:55326983-55327991	K562	blood:	n/a	chr2:55327566-55327579 chr2:55327205-55327216 chr2:55327204-55327215
11	CEBPB	chr2:55328839-55329536	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr2:55327013-55328046	K562	blood:	n/a	chr2:55327566-55327579 chr2:55327205-55327216 chr2:55327204-55327215
13	CEBPB	chr2:55327042-55327431	ECC-1	luminal epithelium:	n/a	chr2:55327205-55327216 chr2:55327204-55327215
14	CEBPB	chr2:55326821-55328075	Hela-S3	cervix:	n/a	chr2:55327566-55327579 chr2:55327205-55327216 chr2:55327204-55327215
15	CEBPB	chr2:55327096-55327286	K562	blood:	n/a	chr2:55327205-55327216 chr2:55327204-55327215
16	CEBPB	chr2:55327081-55327354	H1-hESC	embryonic stem cell:	n/a	chr2:55327205-55327216 chr2:55327204-55327215
17	CEBPB	chr2:55327008-55328037	A549	lung:	n/a	chr2:55327566-55327579 chr2:55327205-55327216 chr2:55327204-55327215
18	CEBPB	chr2:55326888-55327787	A549	lung:	n/a	chr2:55327566-55327579 chr2:55327205-55327216 chr2:55327204-55327215
19	CEBPB	chr2:55326888-55328104	HCT-116	colon:	n/a	chr2:55327566-55327579 chr2:55327205-55327216 chr2:55327204-55327215
20	CEBPB	chr2:55326985-55328061	IMR90	lung:	n/a	chr2:55327566-55327579 chr2:55327205-55327216 chr2:55327204-55327215
21	CTCF	chr2:55331080-55331230	GM12873	blood:	n/a	n/a
22	CTCF	chr2:55327640-55327790	HRE	kidney:	n/a	n/a
23	CTCF	chr2:55327721-55327723	K562	blood:	n/a	n/a
24	CUX1	chr2:55327341-55327782	K562	blood:	n/a	n/a
25	E2F4	chr2:55329168-55329416	MCF10A-Er-Src	breast:	n/a	n/a
26	E2F4	chr2:55327062-55327640	MCF10A-Er-Src	breast:	n/a	n/a
27	ELK1	chr2:55327734-55327738	K562	blood:	n/a	n/a
28	EP300	chr2:55327416-55327681	SK-N-SH_RA	brain:	n/a	n/a
29	EP300	chr2:55328790-55329738	Hela-S3	cervix:	n/a	chr2:55329264-55329278 chr2:55328998-55329012
30	EP300	chr2:55328820-55329679	SK-N-SH	brain:	n/a	chr2:55329264-55329278 chr2:55328998-55329012
31	EP300	chr2:55326840-55328084	Hela-S3	cervix:	n/a	chr2:55327202-55327216 chr2:55327872-55327886
32	EP300	chr2:55326994-55328013	K562	blood:	n/a	chr2:55327202-55327216 chr2:55327872-55327886
33	EP300	chr2:55327136-55327269	HepG2	liver:	n/a	chr2:55327202-55327216
34	EP300	chr2:55330142-55330591	SK-N-SH_RA	brain:	n/a	n/a
35	EP300	chr2:55329629-55329844	SK-N-SH_RA	brain:	n/a	n/a
36	EP300	chr2:55329597-55329949	SK-N-SH_RA	brain:	n/a	n/a
37	EP300	chr2:55330097-55330777	SK-N-SH	brain:	n/a	n/a
38	EP300	chr2:55330081-55330776	SK-N-SH	brain:	n/a	n/a
39	EP300	chr2:55328904-55330003	SK-N-SH	brain:	n/a	chr2:55329264-55329278 chr2:55328998-55329012
40	EP300	chr2:55327383-55327734	SK-N-SH_RA	brain:	n/a	n/a
41	EP300	chr2:55326885-55327981	SK-N-SH	brain:	n/a	chr2:55327202-55327216 chr2:55327872-55327886
42	EP300	chr2:55330246-55330472	SK-N-SH_RA	brain:	n/a	n/a
43	ESR1	chr2:55327063-55327348	T-47D	breast:	n/a	n/a
44	FOS	chr2:55327040-55327390	MCF10A-Er-Src	breast:	n/a	n/a
45	FOS	chr2:55329167-55329392	MCF10A-Er-Src	breast:	n/a	n/a
46	FOS	chr2:55327024-55327387	MCF10A-Er-Src	breast:	n/a	n/a
47	FOS	chr2:55329063-55329478	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr2:55329112-55329375	MCF10A-Er-Src	breast:	n/a	n/a
49	FOS	chr2:55327025-55327362	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr2:55329089-55329460	MCF10A-Er-Src	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:55327371-55327421	U87	brain:	n/a
2	chr2:55327371-55327421	AG04449	skin:	fetal
3	chr2:55327371-55327421	HCF	heart:	n/a
4	chr2:55327371-55327421	HRPEpiC	eye:	n/a
5	chr2:55327371-55327421	K562	blood:	n/a
6	chr2:55327371-55327421	HRE	kidney:	n/a
7	chr2:55327371-55327421	GM12891	blood:	n/a
8	chr2:55327371-55327421	HCPEpiC	choroid plexus:	n/a
9	chr2:55327371-55327421	HPAEpiC	pulmonary alveolar:	n/a
10	chr2:55327371-55327421	GM06990	blood:	n/a
11	chr2:55327371-55327421	HCT-116	colon:	n/a
12	chr2:55327371-55327421	LNCaP	prostate:	n/a
13	chr2:55327371-55327421	RPTEC	kidney:	n/a
14	chr2:55327371-55327421	AG10803	skin:	n/a
15	chr2:55327371-55327421	BE2_C	brain:	n/a
16	chr2:55327371-55327421	HEK293	kidney:	embryo
17	chr2:55327371-55327421	NH-A	brain:	n/a
18	chr2:55327371-55327421	H1-hESC	embryonic stem cell:	embryo
19	chr2:55327371-55327421	HL-60	blood:	n/a
20	chr2:55327371-55327421	NHBE	bronchial:	n/a
21	chr2:55327371-55327421	HIPEpiC	eye:	n/a
22	chr2:55327371-55327421	CMK	blood:	n/a
23	chr2:55327371-55327421	Jurkat	blood:	n/a
24	chr2:55327371-55327421	MCF-7	breast:	n/a
25	chr2:55327371-55327421	GM19239	blood:	n/a
26	chr2:55327371-55327421	HEEpiC	esophagus:	n/a
27	chr2:55327371-55327421	ProgFib	skin:	n/a
28	chr2:55327371-55327421	A549	lung:	n/a
29	chr2:55327371-55327421	AG09309	skin:	n/a
30	chr2:55327371-55327421	ovcar-3	ovarian:	n/a
31	chr2:55327371-55327421	PrEC	prostate:	n/a
32	chr2:55327371-55327421	Caco-2	colon:	n/a
33	chr2:55327371-55327421	SK-N-SH_RA	brain:	n/a
34	chr2:55327371-55327421	AG09319	gingival:	n/a
35	chr2:55327371-55327421	ECC-1	luminal epithelium:	n/a
36	chr2:55327371-55327421	PANC-1	pancreas:	n/a
37	chr2:55327371-55327421	AG04450	lung:	fetal
38	chr2:55327371-55327421	IMR90	lung:	fetal
39	chr2:55327371-55327421	T-47D	breast:	n/a
40	chr2:55327371-55327421	PFSK-1	brain:	n/a
41	chr2:55327371-55327421	BJ	skin:	n/a
42	chr2:55327371-55327421	HMEC	breast:	n/a
43	chr2:55327371-55327421	GM12878	blood:	n/a
44	chr2:55327371-55327421	MCF10A-Er-Src	breast:	n/a
45	chr2:55327371-55327421	SK-N-SH	brain:	n/a
46	chr2:55327371-55327421	HNPCEpiC	eye:	n/a
47	chr2:55327371-55327421	HCM	heart:	n/a
48	chr2:55327371-55327421	Hepatocyte	liver:	n/a
49	chr2:55327371-55327421	HAEpiC	amniotic membrane:	n/a
50	chr2:55327371-55327421	HRCEpiC	kidney:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:55275100..55278867-chr2:55332257..55335062,4	K562	blood:
2	chr2:55323307..55326609-chr2:55326695..55329491,3	K562	blood:
3	chr2:55326388..55330538-chr2:55335061..55337994,3	K562	blood:
4	chr2:55322759..55325369-chr2:55329915..55332847,3	MCF-7	breast:
5	chr2:55323175..55325737-chr2:55325839..55328414,2	MCF-7	breast:
6	chr2:55327279..55331330-chr2:55337574..55341174,5	K562	blood:
7	chr2:55331372..55335609-chr2:55337059..55340698,6	K562	blood:
8	chr2:55326463..55328844-chr2:55338475..55342420,4	K562	blood:
9	chr2:55278300..55281080-chr2:55325086..55327233,3	K562	blood:
10	chr2:55325626..55328074-chr2:55345685..55348277,2	K562	blood:
11	chr2:55332689..55335529-chr2:55338275..55340328,2	MCF-7	breast:
12	chr2:55312676..55314647-chr2:55325733..55328474,2	K562	blood:
13	chr2:55276735..55279463-chr2:55327258..55330571,3	K562	blood:
14	chr2:55317970..55321435-chr2:55328777..55332297,3	K562	blood:

Variant related genes	Relation type
ENSG00000266376	TF binding region
ENSG00000266376	CpG island
ENSG00000115310	chromatin interactions
ENSG00000266376	chromatin interactions

Extended variants
information (count: 250 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:250 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2968811	chr2:55327091-55327092	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs147233729	chr2:55327098-55327099	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs542767124	chr2:55327105-55327106	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs556787754	chr2:55327117-55327118	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs576758172	chr2:55327172-55327173	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs115008533	chr2:55327203-55327204	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs545695413	chr2:55327210-55327211	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs140713009	chr2:55327216-55327217	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs191903301	chr2:55327224-55327225	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs540992791	chr2:55327311-55327312	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs560723917	chr2:55327357-55327358	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs530070966	chr2:55327371-55327372	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs183951811	chr2:55327372-55327373	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs141599155	chr2:55327387-55327388	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs12464796	chr2:55327407-55327408	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs377520570	chr2:55327418-55327419	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs114512425	chr2:55327491-55327492	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs12464877	chr2:55327550-55327551	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs547730869	chr2:55327605-55327606	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs567596215	chr2:55327611-55327612	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs536743030	chr2:55327620-55327621	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs556724236	chr2:55327631-55327632	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs532477911	chr2:55327650-55327651	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs73936835	chr2:55327778-55327779	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs73936836	chr2:55327779-55327780	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs559216853	chr2:55327849-55327850	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs115136077	chr2:55327933-55327934	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs551239371	chr2:55327935-55327936	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs182682838	chr2:55327942-55327943	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs571466074	chr2:55327944-55327945	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs574394664	chr2:55328014-55328015	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs2968812	chr2:55328072-55328073	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs115159928	chr2:55328133-55328134	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs187136824	chr2:55328175-55328176	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs551908713	chr2:55328177-55328178	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs150900864	chr2:55328191-55328192	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs191581412	chr2:55328205-55328206	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs548238004	chr2:55328208-55328209	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs376877684	chr2:55328243-55328244	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs371164274	chr2:55328247-55328248	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs184255893	chr2:55328259-55328260	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs75494352	chr2:55328288-55328289	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs139373588	chr2:55328337-55328338	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs370022505	chr2:55328344-55328345	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs2968813	chr2:55328465-55328466	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs539137863	chr2:55328501-55328502	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs10172205	chr2:55328504-55328505	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs572591496	chr2:55328557-55328558	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs535322915	chr2:55328560-55328561	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs555369719	chr2:55328561-55328562	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
Mental retardation	19951919	CNVD
Myelofibrosis	22110671	CNVD
Microcephaly	20799320	CNVD
camptodactyly	20799320	CNVD
cognitive delay	20799320	CNVD
prenatal and postnatal growth deficiency	20799320	CNVD
ptosis of eyelids	20799320	CNVD
Maculopathy	20981449	CNVD
2p16.1 microdeletion syndrome	22283845	CNVD
Autism	22579565	CNVD
Autism	16963482	CNVD
Autism	21750575	CNVD
idiopathic intellectual disability	16963482	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Multiple myeloma	16616336	CNVD
Follicular lymphoma	17699855	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	22522925	CNVD
Melanoma	20877625	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:280 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:55316800-55327200	Enhancers	Primary neutrophils fromperipheralblood	blood
2	chr2:55318400-55329600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr2:55320000-55327200	Weak transcription	Rectal Mucosa Donor 29	rectum
4	chr2:55321600-55327400	Weak transcription	Cortex derived primary cultured neurospheres	brain
5	chr2:55321600-55339400	Weak transcription	Thymus	Thymus
6	chr2:55321800-55336400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
7	chr2:55322600-55327200	Enhancers	HUVEC	blood vessel
8	chr2:55322600-55327800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
9	chr2:55322800-55327200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr2:55322800-55327200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
11	chr2:55322800-55327200	Enhancers	Adipose Nuclei	Adipose
12	chr2:55323600-55327200	Enhancers	Osteobl	bone
13	chr2:55323600-55328200	Enhancers	K562	blood
14	chr2:55323600-55330000	Enhancers	HSMM	muscle
15	chr2:55323800-55327200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
16	chr2:55323800-55327200	Enhancers	Dnd41	blood
17	chr2:55323800-55327400	Enhancers	NHDF-Ad	bronchial
18	chr2:55323800-55327800	Enhancers	Brain Hippocampus Middle	brain
19	chr2:55323800-55329800	Enhancers	NH-A	brain
20	chr2:55324000-55327400	Weak transcription	Lung	lung
21	chr2:55324400-55327400	Weak transcription	Rectal Mucosa Donor 31	rectum
22	chr2:55324800-55327600	Weak transcription	Placenta	Placenta
23	chr2:55325200-55327200	Weak transcription	Fetal Muscle Leg	muscle
24	chr2:55325200-55327400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
25	chr2:55325200-55327400	Weak transcription	HUES6 Cell Line	embryonic stem cell
26	chr2:55325200-55340400	Weak transcription	Gastric	stomach
27	chr2:55325400-55327400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
28	chr2:55325400-55327400	Weak transcription	Duodenum Mucosa	Duodenum
29	chr2:55325400-55330400	Weak transcription	Fetal Intestine Small	intestine
30	chr2:55326000-55327200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr2:55326000-55327200	Enhancers	Skeletal Muscle Female	skeletal muscle
32	chr2:55326000-55328000	Enhancers	Primary monocytes fromperipheralblood	blood
33	chr2:55326200-55328400	Enhancers	Primary hematopoietic stem cells short term culture	blood
34	chr2:55326400-55327800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
35	chr2:55326400-55328000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr2:55326400-55328000	Enhancers	Fetal Heart	heart
37	chr2:55326400-55328000	Enhancers	Skeletal Muscle Male	skeletal muscle
38	chr2:55326600-55327200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
39	chr2:55326600-55327200	Enhancers	Brain Anterior Caudate	brain
40	chr2:55326600-55327200	Enhancers	Right Atrium	heart
41	chr2:55326600-55327200	Enhancers	A549	lung
42	chr2:55326600-55327400	Weak transcription	Primary B cells from cord blood	blood
43	chr2:55326600-55327600	Enhancers	HMEC	breast
44	chr2:55326600-55327800	Enhancers	Primary hematopoietic stem cells	blood
45	chr2:55326600-55327800	Flanking Active TSS	Muscle Satellite Cultured Cells	--
46	chr2:55326600-55327800	Enhancers	Fetal Stomach	stomach
47	chr2:55326600-55327800	Enhancers	Ovary	ovary
48	chr2:55326600-55327800	Enhancers	Stomach Mucosa	stomach
49	chr2:55326600-55328000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr2:55326600-55328000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links